Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the safety and effectiveness of the Thoratec HeartMate II Left Ventricular Assist System (LVAS) as a bridge to cardiac transplantation in end-stage heart fail...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Abbott Medical Devices
Collaborators
NCT00181259 · Heart Failure, Congestive
NCT04843371 · Valvular Heart Disease, Pericardial Disease, and more
NCT05208567 · Heart Valve Diseases, Left Ventricular Dysfunction
NCT06080074 · Heart Failure, Cardiogenic Shock, and more
NCT07359690 · Heart Transplantation, Dilated Cardiomyopathy (DCM), and more
University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic Hospital
Phoenix, Arizona
Sharp Memorial Hospital
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions